Tue, Aug 4, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Opalesque Radio

Economic and Financial Outlook for 2014
Radio Feature 88: Sona Blessing in conversation with Anton Brender & Florence Pisani
 
Thursday, December 05, 2013

radio Anton Brender is Head of the Economics Studies Department of Dexia Asset Management and amongst others he is Associate Professor at the Université Paris‑Dauphine. A macro-economist, he specialises in the study of international monetary and financial problems
Florence Pisani is an economist at Dexia Asset Management. She lectures at the Université Paris‑Dauphine.
In February 2010 they published “Global Imbalances and the Collapse of Globalised Finance.”

 Download this feature as MP3 (22.24 MB)

 
Listen to the complete feature
Economic and Financial Outlook for 2014

Duration: 09:43 

 

Or listen to selected sub-features
  • Q1 - Could you share your economic and financial outlook for 2014?
    How robust is the economic recovery in the U.S. and what are your thoughts on the FED's stance?

    Duration: 02:58 


  • Q2 - Some emerging economies have growing external deficits - how vulnerable does it make their respective currencies?

    Duration: 00:59 


  • Q3 - Given that the eurozone still has structural problems (capacity utilisation rates are low) how do you map its growth potential?

    Duration: 00:53 


  • Q4 - Has the eurozone's production potential been lastingly weakened?

    Duration: 00:59  


  • Q5 - In which asset classes should investors be looking to invest in 2014?

    Duration: 01:15 


  • Q6 - How do you see the commodity exporters being impacted by the global economic outlook for 2014?

    Duration: 01:15 


  • Q7 - Do you have a view on the USD and EUR?

    Duration: 01:15 


  • Q8 - Do you have a view on the USD and Japanese Yen?

    Duration: 00:25 



Radio Link
  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,